Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 21 Jul 2025 for Blueprint Medicines Corp.
Filing timeline
BuySaleMichael Landsittel
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Landsittel: trading record in brief
Michael Landsittel, listed as finance chief, appears in our data through filings on Blueprint Medicines Corp shares, published by SEC (Form 4). We count 34 filings; the first trade dates from 1 March 2020 and the latest from 17 July 2025.
On the market, this insider has only sold: 20 sales, €4.5M in total. Other entries cover 7 share grants and 5 option exercises. So far in 2025, the count stands at no purchases and 1 sale.
On 21 July 2025 came the latest disclosure, a transaction in Blueprint Medicines Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Landsittel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
21,353 sharesCommon StockSEC:0001104659-25-069396:0
5,284 shares@ US$88.8018.4% of flowCommon StockSEC:0001415889-25-007392:0
11,000 shares0Common StockSEC:0001415889-25-006603:0
4,409 shares@ US$95.2316.0% of flowCommon StockSEC:0001415889-24-021550:0
2,486 shares@ US$107.1710.2% of flowCommon StockSEC:0001415889-24-013469:0
26,363 shares@ US$1.871.9% of flowCommon StockSEC:0001415889-24-012843:0
10,000 shares@ US$36.0514.0% of flowCommon StockSEC:0001415889-24-012359:0
5,000 shares@ US$36.057.0% of flowCommon StockSEC:0001415889-24-009536:0
5,000 shares@ US$36.056.9% of flowCommon StockSEC:0001415889-24-008593:0
5,003 shares@ US$90.6917.4% of flowCommon StockSEC:0001415889-24-007557:0
12,500 shares0Common StockSEC:0001415889-24-007010:0
2,911 shares@ US$45.725.2% of flowCommon StockSEC:0001415889-23-004557:0
12,500 shares0Common StockSEC:0001415889-23-004264:0
1,328 shares@ US$60.273.0% of flowCommon StockSEC:0001415889-22-002735:0
12,500 shares0Common StockSEC:0001415889-22-002438:0
15 of 15 declarations
